Dose-Finding Study of Afuresertib Administered in Combination With Either Enzalutamide or Aibraterone
Clinical trial NCT02380313 · WITHDRAWN
Trial details
- NCT number
- NCT02380313
- Sponsor
- GlaxoSmithKline
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2017-05-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.